Literature DB >> 1185415

Juvenile Wilson disease: histologic and functional studies during penicillamine therapy.

R J Grand, G F Vawter.   

Abstract

Because the long-term effects of penicillamine on hepatic morphology in Wilson disease are virtually unknown, seven patients with this disorder were studied two to seven years after the onset of drug treatment. All were without symptoms at follow-up. By comparison to initial biopsies (four patients), posttreatment specimens showed either considerable reduction in portal fibrosis (two patients) or no significant change (two patients); portal inflammation and necrosis were greatly diminished or absent in three. In none was there complete restitution of normal architecture. Three patients lacked initial biopsies. In these, portal cirrhosis, inflammation and necrosis, and fatty vacuolization of the hepatocytes were present three, five, and seven years after onset of therapy. Lipofuscin pigment was abundant in follow-up biopsies. The data demonstrate that morphologic improvement is achieved in some patients with Wilson disease receiving penicilliamine, but that this is not predicted by biochemical factors. Sequential biopsies are necessary to evaluate completely the extent of healing.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185415     DOI: 10.1016/s0022-3476(75)80131-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  Wilson disease: histopathological correlations with treatment on follow-up liver biopsies.

Authors:  Sandy Cope-Yokoyama; Milton J Finegold; Giacomo Carlo Sturniolo; Kyoungmi Kim; Claudia Mescoli; Massimo Rugge; Valentina Medici
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Clinical management of Wilson disease.

Authors:  Peter Hedera
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  A review and current perspective on Wilson disease.

Authors:  Mallikarjun Patil; Keyur A Sheth; Adarsh C Krishnamurthy; Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2013-07-06

4.  Changing pattern of chronic liver disease (CLD) in India.

Authors:  S Bhave; A Bavdekar; A Pandit
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

Review 5.  Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring.

Authors:  Karl Heinz Weiss; Wolfgang Stremmel
Journal:  Curr Gastroenterol Rep       Date:  2012-02

6.  The Treatment of Hepatic Fibrosis: Reversal of the Underlying Disease Process.

Authors:  Luis Servin-Abad; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-11

Review 7.  Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al.

Authors:  Prodromos Hytiroglou; Neil D Theise
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

Review 8.  D-Penicillamine: The State of the Art in Humans and in Dogs from a Pharmacological and Regulatory Perspective.

Authors:  Michela Pugliese; Vito Biondi; Enrico Gugliandolo; Patrizia Licata; Alessio Filippo Peritore; Rosalia Crupi; Annamaria Passantino
Journal:  Antibiotics (Basel)       Date:  2021-05-28

Review 9.  Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.

Authors:  Shahbaz Khan; Romil Saxena
Journal:  Adv Anat Pathol       Date:  2021-11-01       Impact factor: 3.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.